Carroll Financial Associates’s Idexx Laboratories IDXX Stock Holding History

Carroll Financial Associates’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$44K	Sell	68 -1	-1%	-$628	﹤0.01%	756
2021 Q3	$42K	Sell	69 -456	-87%	-$306K	﹤0.01%	791
2021 Q2	$331K	Buy	525 +126	+32%	+$69.6K	0.02%	314
2021 Q1	$195K	Sell	399 -218	-35%	-$109K	0.01%	399
2020 Q4	$308K	Buy	617 +249	+68%	+$111K	0.02%	295
2020 Q3	$144K	Buy	368 +99	+37%	+$36.6K	0.01%	407
2020 Q2	$88K	Buy	269 +90	+50%	+$26.1K	0.01%	500
2020 Q1	$43K	Buy	179 +155	+646%	+$40.5K	﹤0.01%	606
2019 Q4	$6K	Hold	24	–	–	﹤0.01%	1205
2019 Q3	$6K	Hold	24	–	–	﹤0.01%	1147
2019 Q2	$6K	Buy	24 +3	+14%	+$739	﹤0.01%	1153
2019 Q1	$4K	Buy	21 +7	+50%	+$1.45K	﹤0.01%	1156
2018 Q4	$2K	Buy	14 +7	+100%	+$1.44K	﹤0.01%	1174
2018 Q3	$1K	Buy	+7	New	+$1.7K	﹤0.01%	1245

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carroll Financial Associates's IDXX Position: Q4 2021 in Review

Carroll Financial Associates reduced its Idexx Laboratories (IDXX) stake by 1.4% in Q4 2021, selling an estimated $628 and leaving 68 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #756.

Carroll Financial Associates first reported a position in IDXX in Q3 2018 and has held it in 14 quarters since. The position peaked at $331K in Q2 2021. 1,108 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

Carroll Financial Associates held 68 shares of Idexx Laboratories worth $44K as of Q4 2021.
Carroll Financial Associates sold 1 Idexx Laboratories share in Q4 2021, an estimated $628.
Idexx Laboratories made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #756 holding.
Carroll Financial Associates first reported a position in Idexx Laboratories in Q3 2018 and has held it in 14 quarters since.
Carroll Financial Associates's Idexx Laboratories position peaked at $331K in Q2 2021.
1,108 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.